Robert A Schnoll1, Brian Hitsman2, Sonja Blazekovic3, Anna Veluz-Wilkins2, E Paul Wileyto3, Frank T Leone4, Janet E Audrain-McGovern3. 1. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, United States. Electronic address: schnoll@mail.med.upenn.edu. 2. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680N Lakeshore Drive, Chicago, IL 60611, United States. 3. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, United States. 4. Pulmonary, Allergy, & Critical Care Division, University of Pennsylvania, Presbyterian Medical Center, 51N. 39th Street, 1st Floor Rear, Philadelphia, PA 19104, United States.
Abstract
BACKGROUND:Transdermal nicotine, with behavioral counseling, is among the most popular approaches used to quit smoking. Yet, 6-month cessation rates rarely exceed 20-25%. Identifying factors associated with cessation success may help researchers and clinicians develop enhanced interventions that can improve quit rates. This study examined longitudinal changes in withdrawal, craving, depression and anxiety symptoms, and alternative reinforcers, from a baseline assessment to a 6-month outcome, as predictors of 6-month smoking cessation outcomes following 8 weeks of nicotine patch treatment and counseling. METHODS: A sample of 180 smokers, who completed an effectiveness trial that provided counseling and 8 weeks of 21mg nicotine patches, was analyzed. Generalized estimating equations evaluated changes in withdrawal and craving, depression and anxiety symptoms, and alternative reinforcers over time, between participants who were smoking at 6-months and participants who were abstinent (confirmed with carbon monoxide) at 6-months. Multiple logistic regression assessed changes in these variables as predictors of relapse. RESULTS: Controlling for covariates associated with cessation (i.e., nicotine dependence, patch adherence, and rate of nicotine metabolism), participants who were abstinent at 6 months showed significantly lower craving and withdrawal and significantly higher substitute reinforcers from baseline to 6 months, vs. those who were smoking at 6 months (p<0.001). An increase in craving predicted relapse to smoking (p<0.05). CONCLUSIONS: These results support continued efforts to strengthen interventions that reduce withdrawal and craving and the development of interventions to address alternative reinforcers in order to promote long-term smoking abstinence following nicotine patch treatment.
RCT Entities:
BACKGROUND: Transdermal nicotine, with behavioral counseling, is among the most popular approaches used to quit smoking. Yet, 6-month cessation rates rarely exceed 20-25%. Identifying factors associated with cessation success may help researchers and clinicians develop enhanced interventions that can improve quit rates. This study examined longitudinal changes in withdrawal, craving, depression and anxiety symptoms, and alternative reinforcers, from a baseline assessment to a 6-month outcome, as predictors of 6-month smoking cessation outcomes following 8 weeks of nicotine patch treatment and counseling. METHODS: A sample of 180 smokers, who completed an effectiveness trial that provided counseling and 8 weeks of 21mg nicotine patches, was analyzed. Generalized estimating equations evaluated changes in withdrawal and craving, depression and anxiety symptoms, and alternative reinforcers over time, between participants who were smoking at 6-months and participants who were abstinent (confirmed with carbon monoxide) at 6-months. Multiple logistic regression assessed changes in these variables as predictors of relapse. RESULTS: Controlling for covariates associated with cessation (i.e., nicotine dependence, patch adherence, and rate of nicotine metabolism), participants who were abstinent at 6 months showed significantly lower craving and withdrawal and significantly higher substitute reinforcers from baseline to 6 months, vs. those who were smoking at 6 months (p<0.001). An increase in craving predicted relapse to smoking (p<0.05). CONCLUSIONS: These results support continued efforts to strengthen interventions that reduce withdrawal and craving and the development of interventions to address alternative reinforcers in order to promote long-term smoking abstinence following nicotine patch treatment.
Authors: Susan L Kenford; Stevens S Smith; David W Wetter; Douglas E Jorenby; Michael C Fiore; Timothy B Baker Journal: J Consult Clin Psychol Date: 2002-02
Authors: Karin A Kasza; K Michael Cummings; Matthew J Carpenter; Monica E Cornelius; Andrew J Hyland; Geoffrey T Fong Journal: Addiction Date: 2014-11-20 Impact factor: 6.526
Authors: Stephen T Higgins; Stacey C Sigmon; Conrad J Wong; Sarah H Heil; Gary J Badger; Robert Donham; Robert L Dantona; Stacey Anthony Journal: Arch Gen Psychiatry Date: 2003-10
Authors: Patricia M Goelz; Janet E Audrain-McGovern; Brian Hitsman; Frank T Leone; Anna Veluz-Wilkins; Christopher Jepson; E Paul Wileyto; Paul A D'Avanzo; Jonathan G Rivera; Robert A Schnoll Journal: Drug Alcohol Depend Date: 2014-02-15 Impact factor: 4.492
Authors: Alicia M Allen; Nermine M Abdelwahab; Samantha Carlson; Tyler A Bosch; Lynn E Eberly; Kola Okuyemi Journal: Addict Behav Date: 2017-09-20 Impact factor: 3.913
Authors: Andrew A Strasser; Valentina Souprountchouk; Amanda Kaufmann; Sonja Blazekovic; Frank Leone; Neal L Benowitz; Robert A Schnoll Journal: Tob Regul Sci Date: 2016-10
Authors: Jonnie Handschin; Brian Hitsman; Sonja Blazekovic; Anna Veluz-Wilkins; E Paul Wileyto; Frank T Leone; Robert A Schnoll Journal: J Smok Cessat Date: 2017-03-09
Authors: Carmela Martínez-Vispo; Rubén Rodríguez-Cano; Ana López-Durán; Carmen Senra; Elena Fernández Del Río; Elisardo Becoña Journal: PLoS One Date: 2019-04-08 Impact factor: 3.240